BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 16219031)

  • 1. Sustained pharmacological blockade of NK1 substance P receptors causes functional desensitization of dorsal raphe 5-HT 1A autoreceptors in mice.
    Guiard BP; Froger N; Hamon M; Gardier AM; Lanfumey L
    J Neurochem; 2005 Dec; 95(6):1713-23. PubMed ID: 16219031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 5-hydroxytryptamine (5-HT)1A autoreceptor adaptive changes in substance P (neurokinin 1) receptor knock-out mice mimic antidepressant-induced desensitization.
    Froger N; Gardier AM; Moratalla R; Alberti I; Lena I; Boni C; De Felipe C; Rupniak NM; Hunt SP; Jacquot C; Hamon M; Lanfumey L
    J Neurosci; 2001 Oct; 21(20):8188-97. PubMed ID: 11588191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blockade of substance P (neurokinin 1) receptors enhances extracellular serotonin when combined with a selective serotonin reuptake inhibitor: an in vivo microdialysis study in mice.
    Guiard BP; Przybylski C; Guilloux JP; Seif I; Froger N; De Felipe C; Hunt SP; Lanfumey L; Gardier AM
    J Neurochem; 2004 Apr; 89(1):54-63. PubMed ID: 15030389
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic fluoxetine treatment selectively uncouples raphe 5-HT(1A) receptors as measured by [(35)S]-GTP gamma S autoradiography.
    Pejchal T; Foley MA; Kosofsky BE; Waeber C
    Br J Pharmacol; 2002 Mar; 135(5):1115-22. PubMed ID: 11877317
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blockade of 5-HT1A receptors by (+/-)-pindolol potentiates cortical 5-HT outflow, but not antidepressant-like activity of paroxetine: microdialysis and behavioral approaches in 5-HT1A receptor knockout mice.
    Guilloux JP; David DJ; Guiard BP; Chenu F; Repérant C; Toth M; Bourin M; Gardier AM
    Neuropsychopharmacology; 2006 Oct; 31(10):2162-72. PubMed ID: 16452992
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional consequences of 5-HT transporter gene disruption on 5-HT(1a) receptor-mediated regulation of dorsal raphe and hippocampal cell activity.
    Mannoury la Cour C; Boni C; Hanoun N; Lesch KP; Hamon M; Lanfumey L
    J Neurosci; 2001 Mar; 21(6):2178-85. PubMed ID: 11245702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo control of 5-hydroxytryptamine release by terminal autoreceptors in rat brain areas differentially innervated by the dorsal and median raphe nuclei.
    Hervás I; Bel N; Fernández AG; Palacios JM; Artigas F
    Naunyn Schmiedebergs Arch Pharmacol; 1998 Sep; 358(3):315-22. PubMed ID: 9774218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucocorticoid receptor-dependent desensitization of 5-HT1A autoreceptors by sleep deprivation: studies in GR-i transgenic mice.
    Evrard A; Barden N; Hamon M; Adrien J
    Sleep; 2006 Jan; 29(1):31-6. PubMed ID: 16453979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SB-649915, a novel, potent 5-HT1A and 5-HT1B autoreceptor antagonist and 5-HT re-uptake inhibitor in native tissue.
    Scott C; Soffin EM; Hill M; Atkinson PJ; Langmead CJ; Wren PB; Faedo S; Gordon LJ; Price GW; Bromidge S; Johnson CN; Hagan JJ; Watson J
    Eur J Pharmacol; 2006 Apr; 536(1-2):54-61. PubMed ID: 16571351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of Adult 5-HT1A Autoreceptors Results in a Paradoxical Anxiogenic Response to Antidepressant Treatment.
    Turcotte-Cardin V; Vahid-Ansari F; Luckhart C; Daigle M; Geddes SD; Tanaka KF; Hen R; James J; Merali Z; Béïque JC; Albert PR
    J Neurosci; 2019 Feb; 39(8):1334-1346. PubMed ID: 30552180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of a selective 5-HT reuptake inhibitor in combination with 5-HT1A and 5-HT1B receptor antagonists on extracellular 5-HT in rat frontal cortex in vivo.
    Sharp T; Umbers V; Gartside SE
    Br J Pharmacol; 1997 Jul; 121(5):941-6. PubMed ID: 9222551
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serotonin-1A receptor function in the dorsal raphe nucleus following chronic administration of the selective serotonin reuptake inhibitor sertraline.
    Rossi DV; Burke TF; McCasland M; Hensler JG
    J Neurochem; 2008 May; 105(4):1091-9. PubMed ID: 18182050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preferential potentiation of the effects of serotonin uptake inhibitors by 5-HT1A receptor antagonists in the dorsal raphe pathway: role of somatodendritic autoreceptors.
    Romero L; Artigas F
    J Neurochem; 1997 Jun; 68(6):2593-603. PubMed ID: 9166757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Substance P neurokinin 1 receptor activation within the dorsal raphe nucleus controls serotonin release in the mouse frontal cortex.
    Guiard BP; Guilloux JP; Reperant C; Hunt SP; Toth M; Gardier AM
    Mol Pharmacol; 2007 Dec; 72(6):1411-8. PubMed ID: 17890358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antidepressant-like activity of selective serotonin reuptake inhibitors combined with a NK1 receptor antagonist in the mouse forced swimming test.
    Chenu F; Guiard BP; Bourin M; Gardier AM
    Behav Brain Res; 2006 Sep; 172(2):256-63. PubMed ID: 16806519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Mechanism of action of antidepressant drugs: importance of genetically modified mice in the pharmacological in vivo approach].
    Gardier A
    Therapie; 2005; 60(5):469-76. PubMed ID: 16433012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aging alters in a region-specific manner serotonin transporter sites and 5-HT(1A) receptor-G protein interactions in hamster brain.
    Duncan MJ; Hensler JG
    Neuropharmacology; 2002 Jul; 43(1):36-44. PubMed ID: 12213257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute treatment with the antidepressant fluoxetine internalizes 5-HT1A autoreceptors and reduces the in vivo binding of the PET radioligand [18F]MPPF in the nucleus raphe dorsalis of rat.
    Riad M; Zimmer L; Rbah L; Watkins KC; Hamon M; Descarries L
    J Neurosci; 2004 Jun; 24(23):5420-6. PubMed ID: 15190115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of the potential antidepressant OPC-14523 [1-[3-[4-(3-chlorophenyl)-1-piperazinyl]propyl]-5-methoxy-3,4-dihydro-2-quinolinone monomethanesulfonate] a combined sigma and 5-HT1A ligand: modulation of neuronal activity in the dorsal raphe nucleus.
    Bermack JE; Haddjeri N; Debonnel G
    J Pharmacol Exp Ther; 2004 Aug; 310(2):578-83. PubMed ID: 15044555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Substance P (neurokinin 1) receptor antagonists enhance dorsal raphe neuronal activity.
    Conley RK; Cumberbatch MJ; Mason GS; Williamson DJ; Harrison T; Locker K; Swain C; Maubach K; O'Donnell R; Rigby M; Hewson L; Smith D; Rupniak NM
    J Neurosci; 2002 Sep; 22(17):7730-6. PubMed ID: 12196596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.